Back to search
FDAFDA · Food and drugs·Recall number D-0547-2018

SyrSpend SF Suspending Base, a) 500 mL (NDC 51552-1079-5) and b) 4 L (NDC 51552-1079-9), Rx Only, Manufactured by Fagron Inc. St. Paul, MN 55120

Published March 7, 2018 · Recall initiated: February 14, 2018

Summary

FDA records drug Class II recall D-0547-2018, published March 7, 2018 and initiated February 14, 2018. Recalling firm: Fagron, Inc; Status: Terminated; Reported quantity: a) 1007 bottles (500 mL) and b) 738 bottles (4 L); Lot: a) 17I28-U80-039976, exp. 10/02/2020; b) 17I28-U80-039977, exp. 10/02/2020. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Microbial contamination of Non-Sterile Product; product contamination with yeast and mold (Paecilomyces saturatus and Aspergillus fumigatus).

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Fagron, Inc
Distributor
Nationwide, USA
Lot
a) 17I28-U80-039976, exp. 10/02/2020; b) 17I28-U80-039977, exp. 10/02/2020
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was SyrSpend SF Suspending Base, a) 500 mL (NDC 51552-1079-5) and b) 4 L (NDC 51552-1079-9), Rx Only, Manufactured by Fagron Inc. St. Paul, MN 55120 recalled?

Yes. FDA published recall D-0547-2018 on March 7, 2018. Reported hazard: Microbial contamination of Non-Sterile Product; product contamination with yeast and mold (Paecilomyces saturatus and Aspergillus fumigatus).

What should I do if I have this product?

Voluntary: Firm initiated · Letter